Navamedic ASA: Invitation to 2021 Third quarter presentation Published: 28.10.2021 Navamedic ASA extends exclusive distribution rights for Mysimba in the Nordics Published: 12.10.2021 Navamedic ASA receives approval for conditional reimbursement for Mysimba® in Finland Published: 07.09.2021 Navamedic ASA: Q2 and first half 2021 financial results Published: 13.08.2021 Navamedic ASA: Invitation to 2021 Second quarter presentation Published: 10.08.2021 Obesity patient support program launched in Norway Published: 20.05.2021 FirstPrevious56789NextLast
Navamedic ASA receives approval for conditional reimbursement for Mysimba® in Finland Published: 07.09.2021